Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235722 (US10117875, Example 64 | US9359361, 64) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.95E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235718 (US10117875, Example 60 | US9359361, 60) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.18E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235727 (US10117875, Example 70 | US9359361, 70) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 137 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235717 (US10117875, Example 59 | US9359361, 59) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 991 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235721 (US10117875, Example 63 | US9359361, 63) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 112 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235732 (US10117875, Example 66 | US9359361, 66) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 181 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235719 (US10117875, Example 61 | US9359361, 61) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235713 (US10117875, Example 1 | US9359361, 1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 285 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235725 (US10117875, Example 68 | US9359361, 68) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 273 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235715 (US10117875, Example 56 | US9359361, 56) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 317 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235728 (US10117875, Example 71 | US9359361, 71) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.82E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235731 (US10117875, Example 74 | US9359361, 74) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 901 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235723 (US10117875, Example 65 | US9359361, 65) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 198 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235724 (US10117875, Example 67 | US9359361, 67) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235729 (US10117875, Example 72 | US9359361, 72) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 487 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235716 (US10117875, Example 57 | US9359361, 57) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 113 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235720 (US10117875, Example 62 | US9359361, 62) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.49E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235714 (US10117875, Example 54 | US9359361, 54) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 62 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235730 (US10117875, Example 73 | US9359361, 73) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 124 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Toll-like receptor 9 (Homo sapiens (Human)) | BDBM235726 (US10117875, Example 69 | US9359361, 69) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.48E+3 | n/a | n/a | n/a | n/a | n/a | 37 |
JANUS BIOTHERAPEUTICS, INC. US Patent | Assay Description Day 1: A cell suspension of HEK-Blue™-hTLR9 cells at ~450,000 cells per ml in test medium which contained 5% (v/v) heat inactivated FBS was pre... | US Patent US9359361 (2016) BindingDB Entry DOI: 10.7270/Q2GH9GT3 | |||||||||||
More data for this Ligand-Target Pair |